Cargando…
Clinically relevant molecular subtypes and genomic alteration-independent differentiation in gynecologic carcinosarcoma
Carcinosarcoma (CS) of the uterus or ovary is a rare, aggressive and biphasic neoplasm composed of carcinoma and sarcoma elements. Previous genomic studies have identified the driver genes and genomic properties associated with CS. However, there is still no molecular subtyping scheme with clinical...
Autores principales: | Gotoh, Osamu, Sugiyama, Yuko, Takazawa, Yutaka, Kato, Kazuyoshi, Tanaka, Norio, Omatsu, Kohei, Takeshima, Nobuhiro, Nomura, Hidetaka, Hasegawa, Kosei, Fujiwara, Keiichi, Taki, Mana, Matsumura, Noriomi, Noda, Tetsuo, Mori, Seiichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6823358/ https://www.ncbi.nlm.nih.gov/pubmed/31672974 http://dx.doi.org/10.1038/s41467-019-12985-x |
Ejemplares similares
-
A Study of Prognostic Factors of Chinese Patients with Gynecologic Tract Carcinosarcomas Prognosis of Gynecologic Carcinosarcomas
por: Ye, Dan, et al.
Publicado: (2020) -
Oral leukoplakia, a precancerous lesion of squamous cell carcinoma, in patients with long-term pegylated liposomal doxorubicin treatment
por: Nomura, Hidetaka, et al.
Publicado: (2018) -
MR Imaging of Secondary Massive Ovarian Edema Caused by Ovarian Metastasis from Appendiceal Adenocarcinoma
por: Tanaka, Yumiko Oishi, et al.
Publicado: (2018) -
Comparison of secondary cytoreductive surgery plus chemotherapy with chemotherapy alone for recurrent epithelial ovarian, tubal, or peritoneal carcinoma: A propensity score-matched analysis of 112 consecutive patients
por: Takahashi, Akimasa, et al.
Publicado: (2017) -
Pazopanib as a second line treatment for uterine and ovarian carcinosarcoma: a single institutional study
por: Nishikawa, Tadaaki, et al.
Publicado: (2017)